1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Data-Driven Phenotyping of Presymptomatic Type 1 Diabetes Using Longitudinal Autoantibody Profiles
- Contribution to journal › Article
- 2023
-
Mark
Quantifying the utility of islet autoantibody levels in the prediction of type 1 diabetes in children
- Contribution to journal › Article
-
Mark
Refining the Definition of Stage 1 Type 1 Diabetes : An Ontology-Driven Analysis of the Heterogeneity of Multiple Islet Autoimmunity
- Contribution to journal › Article
- 2022
-
Mark
Islet Autoantibody Levels Differentiate Progression Trajectories in Individuals with Presymptomatic Type 1 Diabetes
- Contribution to journal › Article
-
Mark
Islet Autoantibody Type-Specific Titer Thresholds Improve Stratification of Risk of Progression to Type 1 Diabetes in Children
- Contribution to journal › Article
-
Mark
Progression of type 1 diabetes from latency to symptomatic disease is predicted by distinct autoimmune trajectories
- Contribution to journal › Article
- 2021
-
Mark
Imputing Longitudinal Growth Data in International Pediatric Studies : Does CDC Reference Suffice?
- Contribution to journal › Article
-
Mark
Islet Autoimmunity and HLA Markers of Presymptomatic and Clinical Type 1 Diabetes : Joint Analyses of Prospective Cohort Studies in Finland, Germany, Sweden, and the U.S
- Contribution to journal › Article
- 2020
-
Mark
Predicting Type 1 Diabetes Onset using Novel Survival Analysis with Biomarker Ontology
- Contribution to journal › Article
